SEYED EBRAHIM KASSAIAN to Percutaneous Coronary Intervention
This is a "connection" page, showing publications SEYED EBRAHIM KASSAIAN has written about Percutaneous Coronary Intervention.
Connection Strength
1.855
-
Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study. Tex Heart Inst J. 2016 Apr; 43(2):126-30.
Score: 0.356
-
Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. Cardiovasc Diabetol. 2012 Jul 17; 11:82.
Score: 0.275
-
The Association Between Modified Intracoronary Thrombus Grade and Cardiovascular Risk Factors and Initial Laboratory Findings in Patients Undergoing Primary Percutaneous Coronary Intervention. Crit Pathw Cardiol. 2019 09; 18(3):135-138.
Score: 0.113
-
Effect of Various Degrees of Chronic Kidney Disease on Long-term Outcome of Patients with Percutaneous Coronary Intervention. Arch Iran Med. 2019 05 01; 22(5):247-251.
Score: 0.110
-
Effect of Age on Procedural Success, Complications, and Clinical Outcome From a Large Angioplasty Registry. Crit Pathw Cardiol. 2019 03; 18(1):23-31.
Score: 0.109
-
Predictors of Long-term Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly. Arch Iran Med. 2018 08 01; 21(8):344-348.
Score: 0.105
-
Impact of Sex on Long-term Clinical Outcomes After Percutaneous Coronary Intervention. Crit Pathw Cardiol. 2017 12; 16(4):161-166.
Score: 0.100
-
Predictors of major adverse cardiac events following elective stenting of large coronary arteries. Indian Heart J. 2018 Jan - Feb; 70(1):20-23.
Score: 0.097
-
Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors. Crit Pathw Cardiol. 2016 09; 15(3):89-94.
Score: 0.092
-
Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry. Ther Adv Cardiovasc Dis. 2016 Aug; 10(4):206-13.
Score: 0.088
-
The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study. Anatol J Cardiol. 2015 May; 15(5):348-53.
Score: 0.083
-
Selective versus exclusive use of drug-eluting stents in treating multivessel coronary artery disease: a real-world cohort study. Tex Heart Inst J. 2014 Oct; 41(5):477-83.
Score: 0.080
-
Percutaneous coronary intervention to treat chronic total occlusion: predictors of technical success and one-year clinical outcome. Tex Heart Inst J. 2014 Feb; 41(1):40-7.
Score: 0.077
-
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. J Affect Disord. 2014 Feb; 155:216-22.
Score: 0.075
-
A case of successful percutaneous coronary intervention for chronic total occlusion using the reversed guidewire technique. Cardiovasc Interv Ther. 2013 Jul; 28(3):282-6.
Score: 0.071
-
Sex-dependent effects of diabetes mellitus on the revascularization rate in mid-term follow up of young patients with coronary artery disease. J Diabetes Complications. 2017 Dec; 31(12):1686-1690.
Score: 0.024